Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GLYCOPYRRONIUM Cause Therapeutic product effect incomplete? 83 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Therapeutic product effect incomplete have been filed in association with GLYCOPYRRONIUM (Qbrexza). This represents 6.3% of all adverse event reports for GLYCOPYRRONIUM.

83
Reports of Therapeutic product effect incomplete with GLYCOPYRRONIUM
6.3%
of all GLYCOPYRRONIUM reports
0
Deaths
53
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From GLYCOPYRRONIUM?

Of the 83 reports, 53 (63.9%) required hospitalization, and 3 (3.6%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GLYCOPYRRONIUM. However, 83 reports have been filed with the FAERS database.

What Other Side Effects Does GLYCOPYRRONIUM Cause?

Mydriasis (280) Dry mouth (237) Asthma (227) Dyspnoea (225) Vision blurred (182) Off label use (166) Drug ineffective (125) Wheezing (120) Urinary retention (105) Cough (103)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which GLYCOPYRRONIUM Alternatives Have Lower Therapeutic product effect incomplete Risk?

GLYCOPYRRONIUM vs GLYCOPYRRONIUM\INDACATEROL GLYCOPYRRONIUM vs GOLD GLYCOPYRRONIUM vs GOLD THIOMALATE GLYCOPYRRONIUM vs GOLIMUMAB GLYCOPYRRONIUM vs GOLODIRSEN

Related Pages

GLYCOPYRRONIUM Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete GLYCOPYRRONIUM Demographics